IDEXX Laboratories Inc (NASDAQ:IDXX) released its fourth quarter and full-year 2025 earnings presentation on February 2, 2026, showcasing strong revenue growth despite headwinds in veterinary clinical ...
IDEXX’s performance underscores the company’s strong market position and the increasing utilization of diagnostics in veterinary care. Quarterly Performance Highlights IDEXX reported Q2 2025 revenue ...
IDEXX Laboratories Inc (NASDAQ:IDXX) released its Q1 2025 earnings presentation on May 1, 2025, revealing solid performance despite headwinds in clinical visit trends. The veterinary diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results